baber/WOPTO huggingface dataset:
Patent NZ-588691-A (NZ)
Title: Biodegradable disposable absorbent diaper
Inventor: CANALES ESPINOSA DE LOS MONTEROS CARLOS
IPC: A61L15/62
Filed: 2009-05-08
Abstract: Disclosed is a disposable nappy or absorbent clothing article that contains at least 50% of sustainable or biodegradable components for better disposal. The disposable absorbent article comprises a permeable top layer, an impermeable back layer, an absorbent matrix containing absorbent material fibres particles of superabsorbent material placed between the top and back layers, external barriers cuffs, waist and crotch elastic means a fastening system, and a bonding means. At least 50% of the elements contain sustainable or biodegradable compounds and, of this 50% of elements, at least one contains sustainable compounds and at least one contains biodegradable compounds.
Patent NZ-589519-A (NZ)
Title: Disinfecting formulation comprising essential oils, alcohol, gelling agent, emollient and water
Inventor: STEVE PETER LAWRENCE
IPC: A61K8/34
Filed: 2009-04-24
Abstract: Disclosed is a disinfecting formulation comprising, by volume: (a) from about 65 percent to about 75 percent alcohol (for example ethanol, methanol, isopropanol); (b) from about 10 per cent to about 25 per cent of one or more essential oils comprising cineole (for example eucalyptus, tea tree, bay leaf, spearmint and rosemary oils); (c) from about 0.5 per cent to about 5 per cent of a gelling agent (for example petroleum wax); (d) from about 1 percent to about 4 percent of one or more emollient agents (for example glycerine); and (e) water. Also disclosed is a method for making the disinfecting formulation.
Patent NZ-590746-A (NZ)
Title: Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
Inventor: GANGAKHEDKAR ARCHANA
IPC: A61K31/16
Filed: 2009-08-19
Abstract: Disclosed are prodrugs of methyl hydrogen fumarate (monomethyl fumarate) according to formula (I), and methods for their preparation. Specific examples of compounds of formula (I) include: (N,N-diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, bis-(2-methoxyethylamino)carbamoyl]methyl methyl (2E)but-2-ene-1,4-dioate, 1-{ 2-{ (2E)-3-(methoxycarbonyl)prop-2-enoyloxy]acetyl} (2S)pyrrolidine-2-carboxylic acid, (N-{ [tert-butyl)oxycarbonyl]methyl} -N-methylcarbamoyl)methyl methyl (2E)but-2ene1,4-dioate, and (1S)-1-[N,N-bis(2-methoxyethyl)carbamoyl]ethyl methyl (2E)but-2-ene-1,4-dioate. Compounds of formula (I) are useful for treating psoriasis, asthma, chronic obstructive pulmonary disease, cardiac insufficiency, left ventricular insufficiency, myocardial infarction, angina pectoris, Parkinson's disease, Alzheimer's disease, Huntington's disease, retinopathia pigmentosa, mitochondrial encephalomyopathy, transplantation rejection, multiple sclerosis,ischemia, reperfusion injury, AGE induced genome damage, inflammatory bowel disease, Crohn's disease, or ulcerative colitis.
Patent NZ-592712-A (NZ)
Title: Manipulation of organic acid biosynthesis and secretion with cirate synthase
Inventor: SPANGENBERG GERMAN
IPC: C12N15/29
Filed: 2004-04-14
Abstract: Disclosed is a substantially purified or isolated citrate synthase polypeptide including an amino acid sequence selected from the group consisting of sequences shown in Figures 100, 115, 119 and 123 hereto (SEQ ID NOS 328, 350, 352 and 354 respectively); and functionally active variants thereof having at least approximately 90% identity to the recited sequences. Further disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding citrate synthase (CS), or complementary or antisense to a sequence encoding CS, and including a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 99, 101, 114, 118 and 122 hereto (SEQ ID NOS 327, 329 to 335, 349, 351 and 353 respectively); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); (d) functionally active fragments and variants having at least approximately 95% identity to the functional part of the sequences recited in (a), (b) and (c) and having a size of at least 60 nucleotides; and (e) RNA sequences corresponding to the sequences recited in (a), (b), (c) and (d).
Patent NZ-598376-A (NZ)
Title: Cheese-containing food and method for producing same
Inventor: ABE TADAHIRO
IPC: A01J27/04
Filed: 2010-09-22
Abstract: Disclosed is a method for producing a cheese-containing food, the method comprising: a step (1) of heating a soft cheese-containing mixture comprising 70 to 100% by mass of a soft cheese using a Joule heater, and a step (2) of stirring the heated soft cheese-containing mixture under shearing in a high speed shear cooker, wherein a series of steps including the steps (1) and (2) is performed at least twice.
Patent NZ-600937-A (NZ)
Title: Wind based load isolated electrical charging system
Inventor: ARUMUGAM RAJENDRA BABU
IPC: B60L8/00
Filed: 2010-12-02
Abstract: Disclosed is an electric vehicle with drive motor (8), motor speed controller (7), gear and brake mechanism and acceleration means. The vehicle includes a power supply system with wind based charging units with wind generator (1), power supply units having energy storage devices (2) including voltage controller, intermediate section (5), combiner and bypass switch (11). The supply to the drive motor (8) is shared among the power supply units and the intermediate section (5) is such that during first half cycle of its operation the energy storage devices (2) of a power supply unit PS1 are set in parallel configuration and are connected to the output of the wind generator (1) for recharging and simultaneously the energy storage devices (2) of other power supply unit PS2 are set in series configuration and are connected to supply the drive motor (8) while the other wind generator is kept is free rotation and during second half cycle the vice versa of the above operation takes place with complete isolation of the recharging system from the drive load.
Patent NZ-601360-A (NZ)
Title: Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
Inventor: SINGH JASBIR
IPC: C07D417/06
Filed: 2008-11-20
Abstract: 601360 Disclosed are fused bicyclic compounds of either thiazole or oxazole with a six-membered ring of formula (I) where the substituents are as disclosed in the specification. Examples of compound of formula (I) include 2-Amino-6-(4-amino-benzyl)-4-(3-nitro-phenyl)-benzothiazol-5-ol; 7-Benzo[1,3]dioxol-5-yl-5-(4-fluorobenzyl)-thiazolo[5,4-d]pyrimidin-2-ylamine and { 4-[4-(3-Chloro-phenyl)-benzothiazol-6-ylmethyl]-phenyl} -urea. Also disclosed are pharmaceutical compositions comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for treating stroke, myocardial infarct, cardiovascular inflammatory conditions, cancer, asthma, COPD, bone loss, bladder inflammation, bladder over activity or pain arising from bladder inflammation.
Patent NZ-604082-A (NZ)
Title: Method for treating multiple sclerosis
Inventor: FROHNA PAUL A
IPC: C07K16/28
Filed: 2005-06-02
Abstract: Disclosed is a use of a CD20 antibody in the manufacture of a medicament for use in treating multiple sclerosis in a subject wherein the medicament is administered; and/or is formulated to provide an initial antibody exposure of about 0.5 to 4 grams followed by a second antibody exposure of about 0.5 to 4 grams, the second exposure not being provided until from about 16 to 60 weeks from the initial exposure, and each of the antibody exposures is provided to the subject as one or two doses of antibody, and wherein the antibody is a humanised CD20 antibody comprising a light chain comprising a CDR L1 having the amino acid sequence RASSSVSYMH, a CDR L2 having the amino acid sequence APSNLAS, and a CDR L3 having the amino acid sequence QQWSFNPPT, and a heavy chain comprising a CDR H1 having the amino acid sequence GYTFTSYNMH, a CDR H2 having the amino acid sequence AIYPGNGDTSYNQKFKG, and a CDR H3 having the amino acid sequence VVYYSNSYWYFDV.
Patent NZ-610538-A (NZ)
Title: Fgfr1 extracellular domain combination therapies
Inventor: LONG LI
IPC: C07K19/00
Filed: 2011-11-14
Abstract: Disclosed is the use of a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) fusion molecule and at least one additional therapeutic agent selected from docetaxel, vincristine, and topotecan for the manufacture of a medicament for treating cancer in a subject, wherein the medicament is formulated for administration of an effective amount of the FGFR1 ECD fusion molecule and the at least one additional therapeutic agent to the subject, wherein the FGFR1 ECD fusion molecule comprises an FGFR1 ECD comprising an amino acid sequence selected from SEQ ID NOs: 1 to 4 and a fusion partner, and wherein administration of the FGFR1 ECD fusion molecule and the at least one additional therapeutic agent results in synergistic inhibition of tumour growth in a mouse xenograft model of the cancer, wherein the cancer is small cell lung cancer and the mouse xenograft model comprises DMS 53 cells.
Patent NZ-618379-A (NZ)
Title: A tool for applying insulation fasteners
Inventor: MCCULLOUGH DAVID
IPC: F16B15/00
Filed: 2009-11-24
Abstract: A tool for driving a fastener pin into a substrate to secure a fastener body to the substrate for fixing insulation or other cladding is disclosed. The tool comprises a fastener guide (42) and a driving piston driven along the fastener guide by gas pressure to engage and drive the pin. The fastener guide being displaceable axially inwardly relative to the body of the tool in order to cock the tool for firing of the driving piston. The tool also comprises means for enabling the tool to push the fastener body through insulation or other cladding into engagement with the underlying substrate without putting the tool into a condition in which firing can occur, the tool being thereafter able to be put into a condition to permit firing to take place.
Patent NZ-622012-A (NZ)
Title: Sizing composition for mineral wool containing a reducing saccharide and a hydrogenated saccharide, and resulting insulating products
Inventor: OBERT EDOUARD
IPC: D04H3/12
Filed: 2012-07-26
Abstract: Disclosed herein is a bonding composition for insulation products based on mineral wool, wherein the composition comprises: at least one reducing saccharide, preferably a hexose selected from the group consisting of glucose, mannose and galactose, or dextrin, or mixture thereof; at least one hydrogenated saccharide, preferably selected from the group consisting of erythritol, arabitol, xylitol, sorbitol, mannitol, iditol, maltitol, isomaltitol, lactitol, cellobitol, palatinitol, maltotritol and the hydrogenation products of starch hydrolysates, and at least one polyfunctional crosslinking agent selected from the group consisting of organic polycarboxylic acids or salts of these acids, anhydrides and polyaldehydes the hydrogenated saccharide(s) representing 10 to 90% of the total weight of reducing saccharide(s) and of hydrogenated saccharide(s). The disclosure also relates to the resulting mineral-fiber insulating products and to the method for manufacturing same.
Patent NZ-623260-A (NZ)
Title: Improved clamps for panels
Inventor: SCHOPF JOHN
IPC: F16B2/06
Filed: 2010-05-19
Abstract: A clamp (90) for securing a panel such as for a fence or balustrade is disclosed. The clamp comprises a first and second clamping means (94, 96) and a locating component (106). The first and second clamping means (94, 96) and the locating component (106) interlock with each other so that the clamping surfaces (98) press against opposing faces of a panel (92). Each clamping means (94, 96) has a hook like formation (100, 102) which extends partially around the locating component (106). The locating component (106) has a tapered portion (104) so when the locating component (106) is moved longitudinally the formations (100, 102) are forced apart and the clamping surfaces (98) are forced together.
Patent NZ-624392-A (NZ)
Title: Production of propanols, alcohols, and polyols in consolidated bioprocessing organisms
Inventor: SILLERS WILLIAM RYAN
IPC: C12P7/20
Filed: 2010-08-20
Abstract: Disclosed is a recombinant microorganism; wherein said microorganism expresses one or more native and/or heterologous enzymes; wherein said one or more enzymes function in one or more engineered metabolic pathways to convert a carbohydrate source to n-propanol and isopropanol; and wherein said one or more native and/or heterologous enzymes is activated, upregulated or downregulated.
Patent NZ-625092-A (NZ)
Title: Method and server for searching for nearby user in social networking services
Inventor: CHEN JUNCHAO
IPC: H04W4/02
Filed: 2012-08-02
Abstract: Disclosed are a method and server for searching for nearby users in a social network. The method comprises after receiving the position information and a user identifier reported by the client-side of any user X, determining a grid Y where the received position information is located. The method further comprises storing the user identifier and the latest position information of user X only in the list corresponding to grid Y. The grid Y is any one grid in a series of grid arrays with an equal area pre-plotted on the earth surface. The server searches for the users in grid Y and the other grids forming an N-grid structure together with grid Y and taking grid Y as center. The server sequences the searched users in the sequence from proximal to distal according to distances to user X, and returns the user identifiers of the sequenced users and the distances to user X to the client-side of user X. The reporting time can be further considered as another factor in the sequencing process. The method and device of the present invention improve the accuracy of search result.
Patent NZ-625538-A (NZ)
Title: Methods and compositions for producing squalene using yeast
Inventor: BEETHAM PETER R
IPC: C12R1/73
Filed: 2010-11-22
Abstract: Disclosed is a method of producing squalene by a genetically converted or non-genetically converted yeast, said method comprising cultivating said yeast with an antifungal agent; wherein the yeast is a Yarrowia lipolytica strain selected from the group consisting of ATCC 20688, ATCC 90811, ATCC 90904, ATCC 90812, ATCC MYA-2613, or Yeastern polg and wherein the antifungal agent is an allylamine antifungal agent.
Patent NZ-628338-A (NZ)
Title: Drainage body connecting element
Inventor: WICHMANN THORSTEN
IPC: F16B17/00
Filed: 2013-01-23
Abstract: Drain trenches are hollow or lattice bodies which can be installed in the ground and which are intended for receiving surface water and for releasing it slowly into the ground or for storing the water. These hollow or lattice bodies are composed of individual drain trench bodies which have to be fixedly connected to one another. Drain trench body connecting elements e.g. dowels, clips or fasteners (1, 2) for connecting trench bodies are proposed which comprise two spigots (20, 20’) which are connected via a web (21) and which can in each case be inserted into a receiving opening of a drain trench body in such a way that two drain trench bodies are connected to one another via the web (21).
Patent NZ-702469-A (NZ)
Title: Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
Inventor: MOYO VICTOR
IPC: A61P35/00
Filed: 2013-06-12
Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
Patent NZ-702992-A (NZ)
Title: Systems and methods for ex-vivo organ care
Inventor: HASSANEIN WALEED
IPC: A01N1/02
Filed: 2005-10-07
Abstract: Disclosed is a heart preservation and transport system including a single use module for improved organ transplantation. The organ chamber assembly for containing an organ for preservation comprises a housing having a bottom and walls sized for containing the organ, wherein the organ is a heart. An intermediate lid is use for covering an opening to the housing for substantially enclosing the organ within the housing, the intermediate lid including a frame sized to substantially cover an outer rim of the opening. A flexible membrane is attached to and suspended within the frame, the flexible membrane being configured to allow an operator to manipulate an organ contained within the chamber while still maintaining sterility of the system and the organ. The intermediate lid being coupled to the housing an intermediate lid hinge such that the intermediate lid is independently movable from the housing; and an outer lid independently operable from the intermediate lid for covering, at least partially, the intermediate lid, the outer lid being coupled to at least one of the intermediate lid and the housing by an outer lid hinge.
Patent NZ-704858-A (NZ)
Title: Arylethynyl pyrimidines
Inventor: JAESCHKE GEORG
IPC: C07D403/04
Filed: 2013-08-06
Abstract: The present invention relates to ethynyl derivatives of formula I wherein R1 is hydrogen or halogen; R2 is C1-3-alkyl or -(CH2)m-O-CH3; n is 2 or 3; m is 1 or 2; or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof. It has been found that the compounds of general formula I are allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5) with improved properties for the treatment of schizophrenia, cognitive diseases, fragile X syndrome or autism.
Patent NZ-708603-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C12P19/02
Filed: 2012-02-14
Abstract: Disclosed is a method of making a product comprising: providing a saccharified feedstock obtained at least in part from a plant that has been modified with respect to a wild type variety of the plant, the feedstock having been exposed to irradiation from an ion beam, the total dose of irradiation being from about 5 Mrad to about 50 Mrad; and contacting the saccharified feedstock with a microorganism to ferment the saccharified feedstock, the feedstock having an improved nutrient mix for the microorganism relative to the wild type variety, wherein the improved nutrient mix enhances fermentation of the saccharified feedstock by the microorganism.
Patent NZ-716842-A (NZ)
Title: Dynamic indication of time division duplex (tdd) uplink/downlink subframe configurations
Inventor: CHEN WANSHI
IPC: H04L5/14
Filed: 2014-07-14
Abstract: Aspects of the present disclosure relate to techniques for dynamic indication of Time Division Duplex (TDD) Uplink (UL)/Downlink (DL) subframe configuration to User Equipments. A base station may identify one or more anchor subframes and one or more non-anchor subframes in a frame. The base station may dynamically change a UL/DL configuration of the frame used for communicating with a plurality of User Equipments (UEs) and signal the changed configuration using a common downlink control channel capable of being interpreted by the plurality of UEs in at least one of the one or more anchor subframes of the frame. Application of the changed configuration to one or more frames is a function of a location of reception of the common downlink control channel within the frame.
Patent NZ-717628-A (NZ)
Title: Plant growth regulating composition and methods for making and using same
Inventor: WIKELEY PHIL
IPC: A01N43/38
Filed: 2014-09-12
Abstract: Water soluble plant growth regulating compositions in granule form and methods for making and using same. The granules comprise an active medium, a carrier medium and optionally a surfactant, wherein the active medium comprises: a gibberellin, a cytokinin, and an auxin. The inventive compositions are shelf stable and may be completely dissolved in water prior to application on a plant or seed.
Patent NZ-740710-A (NZ)
Title: Secured user credential management
Inventor: AGUILAR-MACIAS HECTOR
IPC: H04L29/06
Filed: 2016-09-06
Abstract: An identity management system prevents users’ credential information from being harvested by phishing attackers. The identity management system can installed as a plug in on users’ devices. Destinations that solicit users’ credential information are verified. For example, web addresses or registered names of websites that receive users’ credential information can be verified against known web addresses or registered names to verify their authenticity. When verification of the authenticity of a destination fails, the credential fields of the website are overlaid with a transparent iframe substitute form to receive and store the credential information entered by the user, the substitute form including hidden input fields that mirror the credential fields of the website. In response to the user attempting to submit the form, they are required to confirm that they want to submit the credential information to the website. Once confirmed, the credential information from the substitute form is inserted into the input field of the website and submitted.
Patent NZ-754427-A (NZ)
Title: Regulation of glucose metabolism using anti-cgrp antibodies
Inventor: SMITH JEFFREY T L
IPC: C07K16/26
Filed: 2014-07-03
Abstract: The present disclosure provides methods for the prevention or treatment of metabolic disorders. In exemplary embodiments, methods of administering an anti-CGRP antibody are provided, optionally in combination with a second agent, wherein peripheral and/or hepatic glucose utilization is increased, thereby preventing or treating diseases and disorders associated with insulin resistance. Compositions comprising an anti-CGRP antibody are also provided, optionally in combination with a second agent, which are suitable for administration to increase peripheral and/or hepatic glucose utilization and thereby prevent or treat diseases and disorders associated with insulin resistance. In another embodiment, a method is provided for identifying an anti-human CGRP antibody (or fragment thereof) that increases peripheral and hepatic glucose utilization for potential use in therapy using a non-human animal model of diabetes, wherein the anti-human CGRP antibody has the same CDRs as antibodies selected from a particular group of alternatives.
Patent NZ-759003-A (NZ)
Title: Binder composition, article, and method for manufacturing article
Inventor: MOON JUN OK
IPC: C08L77/04
Filed: 2018-04-13
Abstract: Provided is a binder composition comprising polylysine, and at least one reducing sugar or a derivative thereof, wherein the polylysine has, in the 1H NMR spectrum, a first peak at 3.2 ppm to 3.4 ppm and a second peak at 3.8 ppm to 4.0 ppm, wherein the ratio (A: B) of the area of the first peak (A) to the area of the second peak is 70:30 to 98:2.
Patent NZ-762923-A (NZ)
Title: Vacuum extraction and sealing of containers
Inventor: SCOTT PETER
IPC: B65B31/02
Filed: 2018-12-06
Abstract: An assembly for evacuating and gassing filled containers having open tops, comprising: (a) a shroud having a closed upper and an open bottom for receiving therein a filled container, the interior of the shroud being larger than the exterior of the container to define an interior portion of the shroud that is exterior to the container; (b) a closure for closing the open bottom of the shroud; (c) a porous barrier positioned over the top opening of the container; (d) at least one port through which air and gasses comprising a modified atmosphere are introduced into and removed from the shroud, simultaneously introduced into and removed from the filled container through the porous barrier and introduced into and removed from the interior portion of the shroud that is exterior to the container; and (e) a conveyance for moving the filled container away from the shroud to a location to be closed while within a housing containing the modified atmosphere.